Proper mammary gland development and function require precise hormonal regulation and bidirectional cross talk between cells provided by means of paracrine factors as well as intercellular junctions; exposure to environmental endocrine disruptors can disturb these processes. Exposure to one such family of chemicals, the brominated flame retardants (BFRs), is ubiquitous. Here, we tested the hypothesis that BFR exposures disrupt signaling pathways and intercellular junctions that control mammary gland development. Before mating, during pregnancy and throughout lactation, female Sprague-Dawley rats were fed diets containing that BFR mixture based on house dust, delivering nominal exposures of BFR of 0 (control), 0.06, 20, or 60 mg/kg/d. Dams were euthanized and mammary glands collected on postnatal day 21. BFR exposure had no significant effects on mammary gland/body weight ratios or the levels of proteins involved in milk synthesis, epithelial-mesenchymal transition, cell-cell interactions, or hormone signalling. However, BFR exposure (0.06 mg/kg/d) down-regulated phospho-ser675 b-catenin (p-b-cat Ser675 ) levels in the absence of any effect on total b-catenin levels. Levels of p-CREB were also down-regulated, suggesting that PKA inhibition plays a role. p-b-cat Ser675 co-localized with b-catenin at the mammary epithelial cell membrane, and its expression was decreased in animals from the 0.06 and 20 mg/kg/d BFR treatment groups. Although b-Catenin signaling was not affected by BFR exposure, the interaction between p-b-cat Ser675 and E-cadherin was significantly reduced. Together, our results demonstrate that exposure to an environmentally relevant mixture of BFR during pregnancy and lactation decreases p-b-cat ser675 at cell adhesion sites, likely in a PKA-dependant manner, altering mammary gland signaling.
easily released into the environment, resulting in ubiquitous human exposure (Besis and Samara, 2012) . In 2008 the Government of Canada adopted a regulation prohibiting the manufacture of certain PBDEs congeners and the use, sale, offer for sale and import of those PBDEs, as well as mixtures, polymers and resins containing these substances (Environment Canada, 2008) . Regulatory action was also adopted for HBCDDs, and should come into force in 2017 (Environment Canada, 2010) . However, because PBDEs and HBCDDs are released from existing furnishings and other common household items and are persistent, human exposure will likely continue for many years.
The main routes of exposure of BFR are through inhalation and ingestion of dust, as well as dietary consumption (Besis and Samara, 2012) . BFR are detected in breast milk, adipose tissue, serum and hair and are bioaccumulative (Hites, 2004; Toms et al., 2009; Zota et al., 2013) . Various BFR congeners have been reported to act as endocrine disruptors. Exposure to PBDEs has been associated with adverse effects on male and female reproductive organs and on steroid and thyroid hormone signaling (Chevrier et al., 2010; Ernest et al., 2012; Lefevre et al., 2016a,b; Lilienthal et al., 2006) . A previous study showed a significant delay in ductal outgrowth in the mammary gland at PND21 after perinatal exposure to DE-71 (Kodavanti et al., 2010) . In vitro, decreased apoptosis and increased proliferation were observed when MCF-7 breast cancer cells were exposed to a combination of PBDEs (BDEs 47, 99, 100, and 209) and estradiol (Kwiecinska et al., 2011) .
Mammary gland development and function involve bidirectional communication, composed of paracrine factors and cell junctions between luminal and myoepithelial cells, and are driven by multiple systemic hormones (Gudjonsson et al., 2005; Hennighausen and Robinson, 2005; Stewart et al., 2015) . Among others, estrogens (E2), progesterone, prolactin, Jak2/Stat5 signaling pathways, and ERBB2/HER2/NEU receptor tyrosine kinases are involved in tertiary ductal branching, alveologenesis and the synthesis of milk during pregnancy and lactation (Gallego et al., 2001; Hewitt et al., 2002; Humphreys et al., 1997; Jackson-Fisher et al., 2004) . Thus, changes in hormonal balance can perturb mammary gland development and function. In accordance, exposure to endocrine disruptors at sensitive periods of life, such as the perinatal life, puberty or pregnancy, have been linked to developmental defect and breast cancer (Cohn et al., 2012; Fenton, 2006) . Those sensitive periods involved proliferation, differentiation and apoptosis events that are tightly orchestrated by signaling pathways.
Intercellular junctions are also required for normal mammary gland function. Dysregulation of junctional proteins is associated with breast developmental defects and cancer (Hatsell et al., 2003; Lanigan et al., 2009; Osanai et al., 2007; Plante and Laird, 2008; Stewart et al., 2015) . Down-regulation and altered localization of junctional proteins are observed following exposure to a variety of pollutants, suggesting that environmental chemicals may alter mammary gland function (Leithe et al., 2010; Plante et al., 2002; Salian et al., 2009; Trosko, 2011) . We recently showed that the composition of gap, adherens, and tight junctions in junctional nexuses and the expression of their components vary during mammary gland development (Dianati et al., 2016) . Notably, gap junction proteins, Cx26, Cx30, and Cx32, adherens junction proteins, E-cadherin and b-catenin, as well as tight junction proteins, claudin 3 and claudin 7, were all up-regulated, while Cx43 and Pcadherin were down-regulated during pregnancy and/or lactation (Dianati et al., 2016) . These data suggest stage-dependent requirements in cell-cell interactions during mammary gland development and a role for hormones and paracrine factors in their regulation (Nguyen et al., 2001; Risek et al., 1995; Rubenstein et al., 2003) . Junctional proteins and their binding partners are also involved in regulating cellular signaling and transduction of signals. Among others, b-catenin plays a pivotal role in mammary gland development and function (Carraway et al., 2005; Hatsell et al., 2003) . b-Catenin can either be bound to E-cadherin at the junctional nexus or act as a transcription factor in collaboration with TCF/Lef DNA-binding proteins. This dual role is controlled, in part, by phosphorylation of b-catenin by various kinases, including PKA, CKia, Akt, and GSK3b (Liu et al., 2002; Roura et al., 1999; Spirli et al., 2013; Taurin et al., 2006) . Thus, dysregulation of b-catenin has been associated with abnormal mammary gland development, with the epithelial-to-mesenchymal transition (EMT) and with breast cancer (Carraway et al., 2005; Hatsell et al., 2003) .
In this study, we tested the hypothesis that exposure to common household flame retardants during pregnancy and lactation alters mammary gland function and signaling pathways. Specifically, we evaluated the effects of an environmentally relevant mixture of PBDE and HBCDD congeners on mammary gland function and development, focusing on: (1) the milk synthesis pathway, (2) hormonal receptors, and (3) the expression, localization and interactions of junctional proteins.
MATERIALS AND METHODS
Exposure to a mixture of BFR. Formulation of the mixture of BFR and preparation of the diets were described previously (Berger et al., 2014; Lefevre et al., 2016a,b; Tung et al., 2016 Tung et al., , 2017 . Briefly, the BFR dietary mixture contained 3 different technical PBDE flame retardant mixtures and an HBCDD mixture that were combined to yield proportions of PBDE and HBCDD congeners that were comparable to median levels measured in Boston house dust Stapleton et al., 2008) . Sufficient mixture was combined with powdered diet (0, 0.75, 250, or 750 mg of BFR mixture/kg diet) to deliver a daily nominal dose of 0, 0.06, 20, or 60 mg/kg of body weight/day (mg/kg/d), respectively. Our lowest dose approximated the maximum human exposure, which was calculated based on the dust ingestion rate of 100 mg/d in children and then converted to rat by scaling ratio of 1:6.9 (human to rat body surface area) Stapleton et al., 2008) . Powdered diets were mixed thoroughly, pelleted and stored at 4 C for no more than 1 month prior to feeding.
Animals. Animals and treatment methods were previously described (Tung et al., 2016) . Briefly, virgin female SpragueDawley rats were obtained from Charles River Laboratories (Charles River, St-Constant, Quebec, Canada). Animals were housed individually in accordance with the Guide to the Care and Use of Experimental Animals prepared by the Canadian Council Protocol 2012-015. Food and water were provided ad libitum; the rats were housed in rooms maintained with a 12L:12D photoperiod, 40%-70% humidity at 20 C-24 C.
Exposure began at least 1 week prior to mating and was maintained during gestation and lactation. Female rats were acclimated to control diets for 1 week and then randomly assigned to 1 of the 4 diet groups prior to the mating. Females in proestrus, as assessed by vaginal cytology, were then caged with proven breeder male Sprague-Dawley rats (maintained on the control diet) overnight. A sperm-positive vaginal swab on the following morning indicated mating and this was considered as gestational day 0. Females were returned to their home cage and provided with water and the appropriate dietary mixture ad libitum throughout gestation and lactation. Litter size was balanced at 8 pups per dam at postnatal day (PND)4. All females (n ¼ 10-17 dams per group) were allowed to deliver (denoted as PND 0), dams were euthanized within 15 min after being separated from pups at PND 21 by abdominal aorta exsanguination under isofluorane anaesthesia. At the time of necropsy, the mammary glands were sampled and preserved differently depending on the downstream applications. Abdominal mammary glands (pair 4) were weighed and immediately flashfrozen in liquid nitrogen; inguinal mammary glands (pair 5) were also flash-frozen. These glands were used for western blot and immunoprecipitation analyses. Mammary gland pairs 2-3 (upper-thoracic and thoracic) were embedded in Tissue-Tek OCT cryomounting compound (VWR International, Ville MontRoyal, Quebec, Canada) on dry ice or fixed in 4% formalin and used for histology and immunofluorescence. All unfixed samples were stored at À80 C.
Western blotting. Frozen tissues were homogenized in ice-cold triple detergent lysis buffer (pH 8) (Tris 50 mM, NaCl 150 mM, 0.02% sodium azide, 0.1% SDS, 1% Nonidet P40, 0.5% sodium deoxycholate) supplemented with 1.25 M of NaF, 1 M of NaVO3 and Halt Protease and Phosphatase Cocktail Inhibitor (Fisher Scientific) and centrifuged at !4000 rpm (10 min at 4 C).
Aliquots of the supernatant were stored at À80 C. Protein concentration was determined using the Pierce BCA protein assay kit (Thermo Scientific, Rockford, Illinois, USA). To perform semiquantitative western blot analysis (Taylor et al., 2013) , total proteins were loaded onto TGX Stain-Free TM Acrylamide gels (BIO-RAD, Mississauga, Ontario, Canada). Immediately after electrophoresis, the gels were transferred onto PVDF membranes using the Trans-Blot Turbo Transfer System (BIO-RAD). Total lane proteins were visualized using the ChemiDoc MP imaging system (BIO-RAD) and quantified using ImageLab 5.2 software (BIO-RAD) for normalization. Membranes were blocked with 5% dry milk in TBS-Tween 0.1% and probed overnight at 4 C with primary antibodies diluted in 5% dry milk or 3% BSA in TBS-Tween 0.1% (Supplementary Table 1 ). Membranes were washed 3 times, for 5 min each, with TBS-Tween 0.1% and probed with secondary antibodies in TBS-Tween 0.1% (Supplementary Table  1 ). The signal was obtained using Clarity TM Western ECL Blotting Substrate (BIO-RAD) and visualized using the ChemiDoc MP imaging system (BIO-RAD). The density of each band was normalized to the total proteins in the lane using ImageLab 5.2 software (BIO-RAD). Protein extracts from 9 randomly picked animals per group were analysed (n ¼ 9).
The acquisition of microscopic images and analysis of immunofluorescence. Immunofluorescence staining and analyses were performed as previously described (Dianati and Plante, 2017) . Briefly, tissue cryosections (7 mm) were fixed in 4% formaldehyde and blocked in 3% BSA dissolved in TBS-Tween 0.1%. Primary antibodies were diluted in TBS-Tween 0.1% solutions and sections were incubated for 60 min at room temperature (or overnight at 4 C) with primary antibodies (Supplementary Table 2 ). Staining was followed by 3 washes (5 min each) with TBS-Tween 0.1%. Sections were incubated with the appropriate secondary antibodies (Supplementary  Table 2 ). Staining was followed by another series of 3 washes. Nuclei were stained with 4 0 , 6-diamidino-2-phenylindole (DAPI), and slides were mounted with Fluoromount-G (Cedarlane, Burlington, Ontario, Canada). Immunofluorescence images were obtained with a Nikon A1Rþ confocal microscopic laser equipped with a spectral detector and analyzed using NISelements software (version 4). P-b-cat ser675 signal was quantified using the area of the immunofluorescence staining relative to that of the nucleus (DAPI) staining for each image. Cryosections from 4 randomly picked animals per group were analysed (n ¼ 4); for each animal, 4 random areas of the section were quantified.
Immunoprecipitation. Immunoprecipitation analyses were done as previously described (Dianati and Plante, 2017) . Briefly, the lysates used for immunoprecipitation were prepared from flash-frozen tissue, as described in the western blot section. Immunoprecipitation was performed using the PureProteome TM Protein G Magnetic Bead System (LSKMAGG02) (Millipore, Etobicoke, Ontario, Canada); 200 ml of lysates containing a total of 500 mg protein were incubated overnight at 4 C with slow agitation with the primary antibody (Supplementary Table 3 ). The next day, 50 ml of magnetic beads were added to the incubated lysate-antibody solution, and the bead-antigen-antibody complex was incubated at room temperature for 90 min with slow agitation. After washes, the bead-antibody-protein complexes were dissociated using 2 consecutive incubations with 20 ml of glycine 0.2M (pH 2.5) to remove the IgG. Immunoprecipitation was followed by western blot analysis (Supplementary Table 3) , as described above, using immun-BlotV R low fluorescence PVDF membranes (BIO-RAD). Membrane signals were detected using either Clarity TM Western ECL Blotting Substrate (BIO-RAD) for HRP antibodies, or directly observed using the ChemiDoc MP imaging system for fluorophores (BIO-RAD). Protein-protein interaction was quantified as a ratio of the signal of the interacting protein to the signal of the precipitated target using ImageLab 5.2 software (BIO-RAD). Mammary gland protein extract from 4 randomly picked animals per group were analysed (n ¼ 4).
Masson's trichrome staining. Cryosections of mammary glands (n ¼ 4) were cut (7 mm) and kept at À80 C. At the time of coloration, sections were retrieved from À80 C and fixed in Bouin's overnight. Sections were then sequentially stained with Weigert's iron hematoxylin (10 min), Biebrich scarlet-acid fuchsin (10 minutes), phosphomolybdic-phosphotungstic acid (20 minutes) and aniline blue (5 min). Sections were washed with warm tap water for 10 min between each coloration step. Finally, the sections were treated with 1% acetic acid for 5 min, dehydrated in an alcohol series (95% and 100%), cleared in xylene for 5 min and mounted using Permount (Fisher Scientific, Burlington, Ontario). Cryosections from 4 randomly picked animals per group were analysed (n ¼ 4); for each animal, !4 random areas of the section were observed.
Statistical analyses. All statistical analyses were done using GraphPad Prism, version 6.01. Normal distribution of each data set and the presence of outliers were verified with a D'Agostino and Pearson omnibus normality test and Grubbs' test (ESD method), respectively. For the data with normal distribution (a ¼ .05), p-value was calculated using a parametric 1-way ANOVA followed by Dunnett's multiple comparison tests; otherwise, a nonparametric Kruskal-wallis followed by Dunn's multiple comparison tests was used.
RESULTS

BFR Treatments Did Not Affect Markers of Milk Synthesis or Mammary Gland Function
Effects of the mixture of BFR on pregnancy outcomes, pup growth and development, as well as on pups' mammary gland development, are reported elsewhere (Tung et al., 2016 (Tung et al., , 2017 or currently under investigation. Exposure to the BFR mixture had no effects on dams mammary gland or body weights (data not shown), or on the ratio of mammary gland to the body weight of the dams (Supplementary Figure 1A) . Mammary gland structure also remained unchanged between control and BFRs treated animals (Supplementary Figure 1B) . However, T4 serum levels were reduced in dams, suggesting potential effects on mammary gland signaling or protein expression (Tung et al., 2016) . The mammary gland levels of b-casein, a major milk protein, (Supplementary Figure 1C) , or of Stat5 and p-Stat5 tyr694 , the down-stream effector of the prolactin receptor/Jak2/Stat5 signaling pathway, were not affected in response to BFR treatments ( Supplementary Figs. 1D and 1E ). We also evaluated the effects of BFR on indicators of epidermal growth factor (EGF), E2, and thyroid hormone signaling pathways. No significant changes were observed in the levels of EGFR/ErbB-1, pEGFR (Tyr1068), ErbB2, ERa, or thyroid hormone receptors a or b in the treated groups compared with controls ( Supplementary  Figure 2) .
Effects of BRF Exposure on b-Catenin Levels and Phosphorylation
We next investigated whether the dual roles of b-catenin as an adherens junction protein and/or in signal transduction were affected by treatment with BFR. Western blot analysis showed that the total protein levels of b-catenin remained unchanged after exposure to BFR ( Figure 1A) . Similarly, the levels of non-pb-cat Ser45 and p-b-cat Tyr654 were not altered in the mammary glands from BFR treatment groups (Figs. 1B and D) . Interestingly, we observed a significant down-regulation of approximatively 50% in p-b-cat Ser675 levels in animal treated with the low BFR dose (0.06 mg/kg/d) compared with control ( Figure 1C ). To investigate whether p-b-cat Ser675 downregulation was associated with a decrease in the levels or change in the activity of Akt (protein kinase B) and glycogen synthase kinase 3beta (GSK-3b), kinases known to be involved in its early phosphorylation on serine (Ser) 552 and Ser33/Ser37/ Thr41, respectively, we determined their total protein levels as well as the levels of phosphorylated forms by western blotting. Protein levels of Akt, p-Akt Figs. 3G and H), were not different between control and BFR-exposed rats. The localisations of E-cadherin, vimentin, Cx43, and Cx32 were also not affected (Supplementary Figure 4) .
Effects of Exposure to BFR on the Interaction of p-b-catser675 With E-Cadherin
We investigated the interaction of p-b-cat Ser675 with E-cadherin, the marker for adherens junctions, since the localization of p-bcat Ser675 at the cell membrane of epithelial cells was decreased in animals from the 0.06 and 20 mg/kg/d BFR treatment groups. Co-immunoprecipitation analysis showed that while E-cadherin was equally precipitated in control and treated animals (Figs. 5A top panel and B), the interaction of b-catenin with Ecadherin tended to be lower (p ¼ .07) in the mammary glands of animals from the 0.06 mg/kg/d treatment group ( Figure 5C) . Interestingly, our results demonstrated that in this treatment group, the p-b-cat Ser675 /E-cadherin interaction was significantly decreased ( Figure 5D ); a nonstatistically significant suppression was also observed in animals from the 20 and 60 mg/kg/d BFR treatment groups ( Figure 5D ). Interaction between p-b-cat Ser675 and E-cadherin was confirmed by performing the reciprocal co-IP (Supplementary Figure 5) .
DISCUSSION
Because mammary gland development requires precise hormonal regulation and environmental endocrine disruptors may disturb this process, here, we investigated the effect(s) of an exposure to an environmentally relevant BFR mixture of during pregnancy and lactation on mammary gland development and function. Interestingly, we found that p-b-cat Ser675 levels were decreased in dams from the low dose, environmentally relevant, BFR treatment group. Furthermore, p-b-cat Ser675 was localized to the cell membrane in the lactating gland. An inhibition of the interaction of p-b-cat Ser675 with E-cadherin was observed that is likely linked with an effect on PKA activity as levels p-CREB, a direct target of PKA, were also down-regulated. Although several studies have examined the effects of in utero and early life exposures to PBDEs and HBCDD on a range of aspects of growth and development, only one determined the effects on mammary gland development in female offspring (Kodavanti et al., 2010) ; in this study, exposure was to a technical mixture, DE-71. To the best of our knowledge, our research is the first to evaluate the effects of BFR exposure during gestation and lactation on mammary gland function and development in dams. Previously, we reported that exposure to the environmentally relevant mixture of BFR found in house dust in utero and during lactation decreased T4 levels, but had no impact on the weights of offspring at the time of weaning, although at later ages body weights were significantly reduced in the 2 highest dose treatment groups (Tung et al., 2016) . This Quantitative western blots were done to evaluate the expression of protein kinases involved in b-catenin phosphorylation Akt (A), Phospho-Akt (Ser473) (B), GSK-3b (C), Phospho-GSK-3b (Ser9) (D), and PKA (E), and of CREB (F) and phospho-CREB (G), a direct target of PKA. The columns represent the means 6 SEM (n ¼ 9) for each band normalized to the total protein level. p-values were calculated with a Kruskal-wallis (A, C-G) or an ANOVA (B) statistical tests. *p .05. observation would suggest that exposure to BFR does not affect the lactation capacity of the dams, but could still dysregulate signaling pathways. We did not have observe treatment-related changes in tissue structure and the protein levels of a broad array of markers of milk synthesis (b-casein) or in measures of hormonal responsiveness (total or phosphorylated Stat5, ER alpha or thyroid hormone receptors), EFG signaling (EGF receptors ErbB-1 and 2, phosphor-ErbB1), adhesion proteins (N-, P-or E-cadherin), intermediate filaments (vimentin), tight junctions (claudin-7, occludin) or gap junctions (Cx32 and Cx43). However, b-catenin activation (p-b-cat
Ser675
) and interaction with E-cadherin were perturbed by low dose treatment with BFR.
p-b-cat Ser675 Expression and Interaction With E-Cadherin Were
Perturbed by Exposure to BFR Exposure to the BFR mixture caused a reduction in the levels of p-b-cat Ser675 immunoreactivity in the dam mammary gland.
Notably, exposures to the lowest dose of BFR had the greatest effect, with a reduction in mean levels to roughly 50% of control, measured using 2 different assays. In dams receiving the intermediate dose, the decrease in p-b-cat Ser675 was significant only when immunofluorescence images were quantified. In dams exposed to the highest dose, p-b-cat Ser675 levels were not different from those observed in control samples. b-catenin phosphorylation at other residues was not altered by BFR exposure. Similarly, the levels of p-b-cat Ser675 associated with immunoprecipitated E-cadherin were more dramatically reduced in mammary glands from dams from the lowest dose treatment groups, whereas samples from dams receiving the higher doses did not differ from control.
It has been suggested that exposure to endocrine disruptors in sensitive periods of life can promote breast cancer (Cohn et al., 2012; Fenton, 2006) . Interestingly, higher levels of polychlorinated biphenyls in early postpartum serum samples in women were correlated with a 6-fold increased risk of breast cancer in women (Cohn et al., 2012) . In our study, we found a significant decrease in b-catenin phosphorylation at Ser675 and a reduced association with E-cadherin but we did not observe a change in b-catenin levels or localisation. Loss of cadherin-bound b-catenin is correlated significantly with poor clinical outcome in breast cancer (Dolled-Filhart et al., 2006) ; perturbing the role of b-catenin in signal transduction leads to precocious alveologenesis, adenocarcinoma, hyperplasia, hyperbranching and lactation defects (Incassati et al., 2010; Tepera et al., 2003; Teuliere et al., 2005) . Interestingly, exposure to the lowest doses of BFR significantly downregulated the p-bcat Ser675 levels in dams in the absence of effects on overall bcatenin levels. The consequences of reduced p-b-cat ser675 for the function and long term health of the lactating mammary gland is not clear. Thus, whether or not these modulations are associated with increased risk of breast cancer remains to be evaluated. b-Catenin possesses many putative phosphorylation sites. Phosphorylation at Ser33, Ser37 and Thr41 by GSK3-b, and at Ser45 by the priming kinase CKia, increases ubiquitination and degradation by proteasomes (Liu et al., 2002) . Alternatively, phosphorylation at Tyr654 increases the binding of b-catenin to E-cadherin in adherens junctions (Roura et al., 1999) . Phosphorylation of b-catenin at Ser675 is less well studied. However, it has been demonstrated that Ser675 phosphorylation prevents b-catenin degradation and thereby promotes its transcriptional activity (Spirli et al., 2013; Taurin et al., 2006) . Consequently, we investigated the protein levels of PKA, Akt and GSK-3b, kinases that are linked to b-catenin phosphorylation (Fukumoto et al., 2001; Gordon and Nusse, 2006; Spirli et al., 2013; Taurin et al., 2006) . Phosphorylation of Akt and GSK3b in BFR treatment groups did not differ from control; although phosphorylation of these kinases is commonly considered as evidence of their activation status, more studies are required to determine whether the activities of those kinases are truly unchanged. Since PKA levels are not indicative of its activation we examined the phosphorylation of CREB, a direct target of PKA (Rosenberg et al., 2002) . Levels of p-CREB were reduced in animals from the 0.06 and 20 mg/kg/d treatment groups, suggesting that treatment with BFR indeed led to an inactivation of PKA that may explain the decrease in p-b-cat Ser675 levels that we observed. Interestingly, alterations of the CREB family of transcription factors are observed in hormono-dependent organs, and their dysregulation are observed in tumors (Rosenberg, et al., 2002) . Since b-catenin transcriptional activation is associated with phosphorylation at Ser675 and transcriptional activity of b-catenin requires its nuclear localisation (Estus et al., 2016; Spirli et al., 2013; Taurin et al., 2006) , we examined whether there was a change in the localisation of this protein after treatment with BFR. We observed a treatment-related reduction in p-b-cat Ser675 immunoreactivity but did not see any apparent decrease in the nuclear localization of p-b-cat Ser675 in mammary gland epithelial cells. Furthermore, our results showed no interaction between p-b-cat Ser675 /Lef1, and no changes in the expression of recognized downstream targets (Boon et al., 2002; Mann et al., 1999; Shtutman et al., 1999) , suggesting that b-catenin signaling is not affected by exposure to BFR.
To further confirm the localisation and involvement of p-bcat Ser675 at cell membrane, we performed an immunoprecipitation assay with E-cadherin, the adherens junction component that interacts with b-catenin at the membrane of luminal epithelial cells. Our co-immunoprecipitation assays demonstrated an interaction between E-cadherin and p-b-cat
Ser675
, thus confirming that b-cat Ser675 was indeed located at cell membrane.
Moreover, a significant decrease in E-cadherin/p-b-cat Ser675 interactions was observed specifically in the mammary glands from dams in the lowest dose BFR treatment group. It is interesting that changes in p-b-cat Ser675 expression in the mammary dramatically in control and BFR-exposed animals. Images were obtained with a Nikon A1Rþ equipped with a spectral detector and analyzed using NIS-elements soft-
ware. E, The columns represent the means 6 SEM (n ¼ 4-7) for p-b-cat ser675 staining normalized to nuclei staining. p-values were calculated with a Kruskal-wallis statistical test. *p .05.
glands of BFR exposed dams were observed most consistently in our lowest dose treatment groups. Nonmonotonic dose response curves and low-dose effects have been reported previously for endocrine active chemicals (Vandenberg et al., 2012) ). Our data suggesting that exposures during pregnancy may influence the function of the maternal mammary gland in a manner that may have consequences for the long-term health sheds light on a very understudied issue. Pregnancy and lactation clearly influence the likelihood of developing mammary gland cancers but there have been very few studies that have probed the possibility that events and exposures during pregnancy can modify this risk. Although we were not able to follow up these observations in this study, our data informs this hypothesis and may encourage others to examine this possibility.
CONCLUSION
The exposure of female rats during pregnancy and lactation to a mixture of BFR representative of those found in house dust significantly reduces the level of p-b-cat Ser675 expression in the mammary glands. This decrease is likely to be PKA-dependent manner and is accompanied by a decrease in p-b-cat Ser675 /Ecadherin interaction at the cell membrane. Although there were no apparent adverse effects on the structure or function of the mammary gland during pregnancy and lactation, these effects may have significant consequences on signal transduction linked to PKA activity. Since the role of endogenous p-b-cat
Ser675
is not yet fully understood, further investigations should establish its role in normal mammary gland development and the consequences of its dysregulation on involution and in long-term on breast cancer.
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